A novel treatment for the prevention of migraines, Aimovig (erenumab-aooe), has received approval from the US Food and Drug Administration (FDA). Read more


The BIOCAPAN Project has been funded for four years by the European Commission. It was started to develop an innovative GMP-grade cell-therapy product to treat diabetes without insulin injections, says Florence Rivera Read more


The Ministry of Health, Labor and Welfare in Japan has granted marketing authorisation for Sanofi's insulin glargine [rDNA origin] injection, 300 u/ml, a next-generation basal insulin for the treatment of type 1 and type 2 diabetes mellitus. Read more


Unilife Corporation has been chosen to act as the sole supplier of cartridge-based wearable injectors for all of Sanofi's applicable large dose volume drugs (excluding insulins). Read more


An injection which can help patients in hospitals and intensive care units with acute life-threatening hypertension has been made available in the UK for the first time. Read more